1. End Of Day Scan: ADX New Downtrend $LLTC $CHSP $AEGR $ETH $PEI $WAFD $SNH $QTWO $DJCI $ANGO

  2. $ANGO: INVESTOR ALERT: Glancy Binkow & Goldberg LLP Investigates Claims on Behalf of Investors of AngioDynamics, ... http://stockwires.com/investor-alert-glancy-binkow-amp-goldberg-llp-investigates-claims-on-behalf-of-investors-of-angiodynamics-inc

  3. % Losers $EXTR $CERE $ISNS $GBSN $CJJD $ANGO $IRG $NSLP $DGLY $QURE $ACH $IHT $INUV $MOBI $TTGT $ROSG $BIOC $YOKU

  4. End Of Day Scan: Ichimoku Cloud Red $YNDX $GNW $RDS/A $PM $MAC $ROSE $HUN $ANGO $ARPI $PVG

  5. @AnalystWire: AngioDynamics ($ANGO) PT, Estimates Cut at Piper Jaffray Following Tough Qtr http://www.streetinsider.com/Analyst+Comments/AngioDynamics+%28ANGO%29+PT%2C+Estimates+Cut+at+Piper+Jaffray+Following+Tough+Qtr/10447859.html?si_client=st

  6. Gainers: $VUZI+15.56% $DCO+14.77% $EXL+14.45% Losers: $ANGO-9.64% $JDST-9.49% $RUSL-9.12% Stock Movers Report: http://community.livevol.com/index.php/market-tools/stocks-on-the-move.html

  7. $ANGO: SHAREHOLDER ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of AngioD... http://stockwires.com/shareholder-alert-law-offices-of-howard-g-smith-announces-investigation-on-behalf-of-investors-of-angiodynamics-inc

  8. $ANGO OI for maturity 04/17/2015. 15.00 Highest put. 17.50 Highest call. http://maximum-pain.com/open-interest.aspx?s=ANGO&e=04/17/2015

  9. $ANGO Max Pain is 15.00 for maturity 04/17/2015. Price = 16.67. http://maximum-pain.com/max-pain.aspx?s=ANGO&e=04/17/2015

  10. Gainers: $VUZI+19.44% $EXL+14.45% $DCO+11.65% Losers: $RUSL-9.61% $ANGO-8.99% $AGX-8.22% Stock Movers Report: http://community.livevol.com/index.php/market-tools/stocks-on-the-move.html

  11. $ANGO Canaccord Genuity analyst Jason Mills lowered his price target on AngioDynamics to $20.00 (from $22.00) following soft Q3 ...

  12. Gainers: $EXL+14.23% $VUZI+12.08% $DCO+9.50% Losers: $ANGO-8.77% $AGX-8.53% $JDST-7.50% Stock Movers Report: http://community.livevol.com/index.php/market-tools/stocks-on-the-move.html

  13. $ANGO 4/10/2015 Canaccord Genuity Reiterated Rating Buy $20.00

  14. 4-star analyst Jason Mills from Canaccord Genuity reiterated a BUY on $ANGO. https://www.tipranks.com/experts/jason-mills

  15. Gainers: $EXL+14.16% $JNUG+9.23% $GE+7.89% Losers: $JDST-9.20% $ANGO-7.29% $PSMT-6.24% Stock Movers Report: http://community.livevol.com/index.php/market-tools/stocks-on-the-move.html

  16. Morning Market Losers $ANGO $CERE $CTXS $EXTR $GBDC $MDCO $QURE http://www.benzinga.com/news/15/04/5397863/morning-market-losers

  17. Canaccord Genuity are Buyers of AngioDynamics ($ANGO) on Weakness http://www.streetinsider.com/Analyst+Comments/Canaccord+Genuity+are+Buyers+of+AngioDynamics+%28ANGO%29+on+Weakness/10448430.html?si_client=st

  18. AngioDynamics s buy rating reiterated at Canaccord Genuity. $20.00 PT. http://www.analystratings.net/stocks/NASDAQ/ANGO/?RegistrationCode=SocialMedia-direct $ANGO

  19. ESP Gap Down: $MDCO $GPS $FIS $EXTR $CTXS $ANGO

  20. Must Watch Stocks for Today $ANGO $CTXS $EXTR $RT $GPS #premarket http://www.benzinga.com/news/earnings/15/04/5397027/must-watch-stocks-for-today

  21. AngioDynamics ($ANGO) PT, Estimates Cut at Piper Jaffray Following Tough Qtr http://www.streetinsider.com/Analyst+Comments/AngioDynamics+%28ANGO%29+PT%2C+Estimates+Cut+at+Piper+Jaffray+Following+Tough+Qtr/10447859.html?si_client=st

  22. $ANGO #AngioDynamics Posts Downbeat Q3 Results, Issues Weak Forecast http://www.benzinga.com/news/earnings/15/04/5396272/angiodynamics-posts-downbeat-q3-results-issues-weak-forecast

  23. After-Hours Losers as of 5:15 p.m.: $EXTR -18.2% $MDCO -8.2% $CTXS -6.8% $ANGO -6.6% $FIS -6.0%

  24. Revealing questions advanced on $ANGO latest transcript http://www.conferencecalltranscripts.org/include/?location=http://seekingalpha.com/article/3061036-angiodynamics-ango-ceo-joseph-devivo-on-q3-2015-results-earnings-call-transcript

  25. AngioDynamics $ANGO Up 3.63% misses by $0.04, miss on revs; guides Q4 EPS & revs below consensus, guides FY15 EPS & revs below consensus